Drugs / CBG
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05272865 | Aug 2023 → Feb 2024 | chemotherapy-induced toxicity, neoplasm | LaSanta S A S | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBG | “Drug: THC:CBG Oral solution of THC (5 mg/mL) \& CBG (5 mg/mL)” NCT05272865 ↗ |
| Route | Oral | “Drug: THC:CBG Oral solution of THC (5 mg/mL) \& CBG (5 mg/mL)” NCT05272865 ↗ |